Hidehito Horinouchi
MD, PhD
Chief, Division of Thoracic Oncology
👥Biography 个人简介
Dr. Hidehito Horinouchi is a senior thoracic oncologist at Japan's National Cancer Center who has been a key investigator in MET inhibitor trials including the VISION trial of tepotinib. He has contributed to understanding MET-driven NSCLC in Asian populations and to establishing MET testing standards in Japanese practice. His research encompasses early-phase trials of novel NSCLC therapeutics.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Hidehito Horinouchi 的研究动态
Follow Hidehito Horinouchi's research updates
留下邮箱，当我们发布与 Hidehito Horinouchi（National Cancer Center Hospital, Tokyo）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment